ANKRD36C: A Potential Drug Target and Biomarker (G400986)

Target Name: ANKRD36C

NCBI ID: G400986

ANKRD36C

ANKRD36C: A Potential Drug Target and Biomarker

Ankyrin repeat domains (ANKRD) are a class of transmembrane proteins that have been identified as potential drug targets in various diseases. One of the ANKRD families, ANKRD36C, has been identified as a potential drug target and biomarker in various diseases, including heart disease, diabetes, and neurodegenerative diseases.

The ANKRD36C protein is a 120-kDa protein that is expressed in various tissues and cells, including cardiac muscle, skeletal muscles, and the central nervous system. It is characterized by a unique ANKRD repeat domain that is composed of 19 conserved amino acids. The ANKRD repeat domain is responsible for the protein's unique structure and function.

The ANKRD36C protein is involved in various physiological processes in the body, including muscle contractions, ion channels, and signaling pathways. It has been shown to play a role in regulating muscle contractions and to participate in the regulation of ion channels, such as the sodium channels that are responsible for muscle action potentials.

In addition to its role in physiological processes, the ANKRD36C protein is also known to be involved in the development and progression of various diseases. For example, it has been shown to be overexpressed in various neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. It has also been shown to be involved in the development of heart disease, including myocardial infarction and hypertension.

The ANKRD36C protein is a potential drug target because of its involvement in various diseases and its unique structure and function. It is also a biomarker because of its ability to be used as a diagnostic tool in various diseases.

One of the ANKRD36C's potential drug targets is the treatment of heart disease. The ANKRD36C protein has been shown to be involved in the regulation of ion channels, including the sodium channels that are responsible for muscle action potentials. By targeting these channels, drugs that can inhibit their activity or modulate their function may be effective in treating heart disease.

Another potential drug target for the ANKRD36C protein is the treatment of neurodegenerative diseases. The ANKRD36C protein has been shown to be involved in the regulation of ion channels, including the sodium channels that are responsible for muscle action potentials. By targeting these channels, drugs that can inhibit their activity or modulate their function may be effective in treating neurodegenerative diseases.

In addition to its potential drug and biomarker applications, the ANKRD36C protein is also of interest as a therapeutic target for other diseases. For example, it has been shown to be involved in the regulation of muscle contractions and to participate in the regulation of ion channels. These functions may be relevant to the treatment of various diseases, including muscle-wasting disorders and chronic pain.

Overall, the ANKRD36C protein is a unique and promising drug target and biomarker that has the potential to revolutionize our understanding of various diseases. Further research is needed to fully understand its role in the regulation of physiological processes and its involvement in the development and progression of diseases.

While the ANKRD36C protein is still in its early stages of research, it is clear that it has the potential to be a valuable tool in the treatment of various diseases. As research continues, we can expect to learn more about its role in the regulation of physiological processes and its involvement in the development and progression of diseases.

Protein Name: Ankyrin Repeat Domain 36C

The "ANKRD36C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ANKRD36C comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets